Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort

Helen Strongman1, Sarah Gadd1, Anthony A Matthews1,2

  • 1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Insights

Cardiovascular disease mortality overtakes cancer mortality in older cancer survivors over time. This shift occurs between 2-17 years post-diagnosis, depending on age and cancer type, highlighting long-term survivorship risks.

Area of Science:

  • Oncology
  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Cancer survivors face elevated risks of developing cardiovascular diseases compared to the general population.
  • Understanding long-term health trajectories in cancer survivorship is crucial for patient care.

Purpose of the Study:

  • To determine if cardiovascular mortality surpasses cancer-specific mortality during cancer survivorship.
  • To identify the time point at which cardiovascular disease becomes the leading cause of death in cancer survivors.

Main Methods:

  • A large cohort study utilizing linked English electronic health records and death registration data.
  • Inclusion of 104,028 adults (≥40 years) with a first diagnosis of one of nine common cancers, followed for at least one year post-diagnosis.
  • Age-stratified mortality rates for cardiovascular disease and cancer were estimated using Poisson models, with crossover points determined by interpolation.

Main Results:

  • Cardiovascular mortality surpassed primary cancer mortality between 2-11 years post-diagnosis in survivors aged ≥80 years.
  • For survivors aged 60-79 years, this crossover occurred between 5-17 years post-diagnosis for seven cancer types.
  • Cardiovascular mortality did not overtake cancer mortality in patients aged 40-59 years during the observation period, with the exception of uterine cancer survivors.

Conclusions:

  • In older cancer survivors (≥60 years), cardiovascular mortality becomes the dominant cause of death over time, surpassing primary cancer mortality.
  • The findings underscore the importance of long-term cardiovascular monitoring in cancer survivorship, particularly for older individuals.
  • While cardiovascular disease may overtake primary cancer mortality, it does not always surpass total cancer mortality.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
309
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
141
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
202
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
285
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
414